Saraswati Sukumar
Affiliations: | Human Genetics | Johns Hopkins University, Baltimore, MD |
Area:
Genetics, Molecular Biology, OncologyGoogle:
"Saraswati Sukumar"Children
Sign in to add trainee| Esak Lee | grad student | (Biomechanics Tree) | |
| Yolanda M. Hillocks-Foster | grad student | 2013 | Johns Hopkins |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li B, Qi F, Zhu F, et al. (2023) Nanoparticle-based combination therapy enhances fulvestrant efficacy and overcomes tumor resistance in ER-positive breast cancer. Cancer Research |
| Visvanathan K, Cope L, Fackler MJ, et al. (2022) Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Pai P, Wang G, Teo WW, et al. (2022) HOXA5-Mediated Stabilization of IκBα Inhibits the NF-κB Pathway and Suppresses Malignant Transformation of Breast Epithelial Cells. Cancer Research. OF1-OF13 |
| Fackler MJ, Tulac S, Venkatesan N, et al. (2022) Development of an automated liquid biopsy assay for methylated markers in advanced breast cancer. Cancer Research Communications. 2: 391-401 |
| Liu J, Guo L, Rao Y, et al. (2022) In situ Injection of pH- and Temperature-Sensitive Nanomaterials Increases Chemo-Photothermal Efficacy by Alleviating the Tumor Immunosuppressive Microenvironment. International Journal of Nanomedicine. 17: 2661-2678 |
| Wang G, Kumar A, Ding W, et al. (2022) Intraductal administration of transferrin receptor-targeted immunotoxin clears ductal carcinoma in situ in mouse models of breast cancer-a preclinical study. Proceedings of the National Academy of Sciences of the United States of America. 119: e2200200119 |
| Smith YE, Wang G, Flynn CL, et al. (2022) Functional Antagonism of Junctional Adhesion Molecule-A (JAM-A), Overexpressed in Breast Ductal Carcinoma In Situ (DCIS), Reduces HER2-Positive Tumor Progression. Cancers. 14 |
| Yan Y, Narayan A, Cho S, et al. (2021) CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer. Oncogene |
| Li J, Downs BM, Cope LM, et al. (2021) Automated and rapid detection of cancer in suspicious axillary lymph nodes in patients with breast cancer. Npj Breast Cancer. 7: 89 |
| Gao D, Liu J, Yuan J, et al. (2021) Intraductal administration of N-methyl-N-nitrosourea as a novel rodent mammary tumor model. Annals of Translational Medicine. 9: 576 |